Community Capital Management’s Pfizer PFE Stock Holding History

Community Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,540	Closed	-$367K	–	96
2020 Q3	$367K	Buy	+10,540	New	+$370K	0.49%	62
2019 Q3	–	Sell	-9,029	Closed	-$371K	–	144
2019 Q2	$371K	Hold	9,029	–	–	0.43%	62
2019 Q1	$364K	Hold	9,029	–	–	0.44%	65
2018 Q4	$374K	Buy	+9,029	New	+$375K	0.55%	50

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Community Capital Management's PFE Position: Q4 2020 in Review

Community Capital Management sold out of Pfizer (PFE) in Q4 2020, closing a stake of 10,540 shares — an estimated $367K sold.

Community Capital Management first reported a position in PFE in Q4 2018 and held it in 4 quarters. The position peaked at $374K in Q4 2018. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

Community Capital Management reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
Community Capital Management sold 10,540 Pfizer shares in Q4 2020, an estimated $367K.
Community Capital Management first reported a position in Pfizer in Q4 2018 and held it in 4 quarters.
Community Capital Management's Pfizer position peaked at $374K in Q4 2018.
2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Community Capital Management's 13F filing for Q4 2020, filed 4 Feb 2021.